Discover
MSLE
Satellos Bioscience Inc.
7.58
1 x 6.97
1 x 7.89
bid
ask
-
0.20
2.51%
1 @ 04:00 PM
7.43 -0.15 (1.98%)
| Ytd | 28.91% | |
| 1y | 21.67% |
7.32
day range
8.01
4.64
52 week range
13.39
| Open | 7.75 | Prev Close | 7.78 | Low | 7.32 | High | 8.01 | Mkt Cap | 157.90M |
| Vol | 35.02K | Avg Vol | 43.64K | EPS | -1.79 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 6.89 | 200-d Avg | 7.41 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 10.04M | ||
| Research and Development Expense | 7.31M | ||
| Selling, General and Administrative Expense | 2.73M | ||
| Operating Income | -10.04M | ||
| Income Tax Expense | 33.00K | ||
| Net Income | -9.77M | ||
| Net Income Common Stock | -9.77M | ||
| Net Income Common Stock (USD) | -9.77M | ||
| Consolidated Income | -9.77M | ||
| Earnings per Basic Share | -0.53 | ||
| Earnings per Basic Share (USD) | -0.53 | ||
| Earnings per Diluted Share | -0.53 | ||
| Earning Before Interest & Taxes (EBIT) | -9.73M | ||
| Earning Before Interest & Taxes (USD) | -9.73M | ||
| Weighted Average Shares | 18.44M | ||
| Weighted Average Shares Diluted | 18.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.70M | ||
| Cash and Equivalents (USD) | 18.70M | ||
| Investments | 51.21M | ||
| Investments Current | 51.21M | ||
| Current Assets | 75.22M | ||
| Property, Plant & Equipment Net | 8.00K | ||
| Total Assets | 75.23M | ||
| Current Liabilities | 4.56M | ||
| Total Liabilities | 4.56M | ||
| Accumulated Retained Earnings (Deficit) | -91.74M | ||
| Accumulated Other Comprehensive Income | -1.70M | ||
| Shareholders Equity | 70.66M | ||
| Shareholders Equity (USD) | 70.66M | ||
| Assets Non-Current | 8.00K | ||
| Trade and Non-Trade Payables | 4.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow from Financing | 51.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.89M | ||
| Capital Expenditure | -4.00K | ||
| Issuance (Purchase) of Equity Shares | 51.90M | ||
| Net Cash Flow from Investing | -33.34M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -33.33M | ||
| Net Cash Flow from Operations | -9.59M | ||
| Effect of Exchange Rate Changes on Cash | -86.00K | ||
| Share Based Compensation | 727.00K | ||